Search - tctmd.com

Displaying 1 - 20 of 74

Sort: Relevancy | Date

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation TCT 2024

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

Presenter: Daria Feshchenko

October 28, 2024

Presentation ACC 2024

Main Results From The Step-hfpef Dm Trial

Presenter: Mikhail Kosiborod

April 06, 2024

Presentation AHA 2023

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

Presenter: Jing Li

November 16, 2023

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Presentation ACC 2023

A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes]

Presenter: Neha J. Pagidipati

March 05, 2023

Presentation Controversies and Advances 2021

What Diet is Best for Cardiovascular Health?

Presenter: Kim Allan Williams, Sr.

December 03, 2021

Presentation TCT 2021

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

Presenter: Alexandra Lansky

November 06, 2021

Presentation TCT 2021

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

Presenter: Rafael Romaguera

November 04, 2021

Presentation ACC 2020

The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: COMPASS Diabetes

Presenter: Deepal L. Bhatt

March 30, 2020

Presentation TCT 2019

Leave It to the Endocrinologist!

Presenter: Sonya Burgess

September 27, 2019

Presentation TCT 2019

The Cardiologist Should Play a Major Role in Diabetes Management!

Presenter: Matthew Cavender

September 27, 2019

Presentation TCT 2019

Don't Forget Anticoagulant Therapy!

Presenter: Sanjit Jolly

September 27, 2019

Presentation TCT 2019

The Case for Short-Term (1-6 Months) DAPT

Presenter: Anand Prasad

September 27, 2019

Presentation TCT 2019

The Case for Long-Term (1 Year+) DAPT

Presenter: Usman Baber

September 27, 2019

Presentation TCT 2019

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Most Contemporary DES Will Provide Similar Outcomes!

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

The Case for PCI in Most!

Presenter: Sripal Bangalore

September 27, 2019

Presentation TCT 2019

The Case for CABG in Most!

Presenter: Michael Borger

September 27, 2019

Advertisement

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

TCT 483: One Year Follow-Up Effect of Renal Sympathetic Denervation After Percutaneous Coronary Intervention in Patients With Resistant Hypertension and Type 2 Diabetes Mellitus

Main Results From The Step-hfpef Dm Trial

Effects of intensive blood pressure lowering treatment in reducing risk of cardiovascular events

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes]

What Diet is Best for Cardiovascular Health?

TARGET AC 4-year Results & Deep Dive in Diabetes Subgroup

SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes

The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: COMPASS Diabetes

Leave It to the Endocrinologist!

The Cardiologist Should Play a Major Role in Diabetes Management!

Don't Forget Anticoagulant Therapy!

The Case for Short-Term (1-6 Months) DAPT

The Case for Long-Term (1 Year+) DAPT

Some Stents Are More Equal Than Others (e.g., Ultra-Thin)!

Most Contemporary DES Will Provide Similar Outcomes!

The Case for PCI in Most!

The Case for CABG in Most!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content